Logo image of LCE.CA

CENTURY LITHIUM CORP (LCE.CA) Stock Fundamental Analysis

TSX-V:LCE - TSX Venture Exchange - CA1566151066 - Common Stock - Currency: CAD

0.245  -0.02 (-5.77%)

Fundamental Rating

2

Taking everything into account, LCE scores 2 out of 10 in our fundamental rating. LCE was compared to 822 industry peers in the Metals & Mining industry. LCE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LCE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LCE has reported negative net income.
In the past year LCE has reported a negative cash flow from operations.
LCE had negative earnings in each of the past 5 years.
In the past 5 years LCE always reported negative operating cash flow.
LCE.CA Yearly Net Income VS EBIT VS OCF VS FCFLCE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M

1.2 Ratios

LCE has a better Return On Assets (-5.70%) than 70.79% of its industry peers.
With a decent Return On Equity value of -5.82%, LCE is doing good in the industry, outperforming 73.70% of the companies in the same industry.
Industry RankSector Rank
ROA -5.7%
ROE -5.82%
ROIC N/A
ROA(3y)-7.6%
ROA(5y)-13.12%
ROE(3y)-7.8%
ROE(5y)-13.39%
ROIC(3y)N/A
ROIC(5y)N/A
LCE.CA Yearly ROA, ROE, ROICLCE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LCE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LCE.CA Yearly Profit, Operating, Gross MarginsLCE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for LCE has been increased compared to 1 year ago.
Compared to 5 years ago, LCE has more shares outstanding
Compared to 1 year ago, LCE has an improved debt to assets ratio.
LCE.CA Yearly Shares OutstandingLCE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
LCE.CA Yearly Total Debt VS Total AssetsLCE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 18.23 indicates that LCE is not in any danger for bankruptcy at the moment.
LCE has a better Altman-Z score (18.23) than 81.70% of its industry peers.
LCE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, LCE is in line with its industry, outperforming 54.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.23
ROIC/WACCN/A
WACCN/A
LCE.CA Yearly LT Debt VS Equity VS FCFLCE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 10.40 indicates that LCE has no problem at all paying its short term obligations.
LCE has a Current ratio of 10.40. This is amongst the best in the industry. LCE outperforms 86.55% of its industry peers.
A Quick Ratio of 10.40 indicates that LCE has no problem at all paying its short term obligations.
LCE has a Quick ratio of 10.40. This is amongst the best in the industry. LCE outperforms 86.55% of its industry peers.
Industry RankSector Rank
Current Ratio 10.4
Quick Ratio 10.4
LCE.CA Yearly Current Assets VS Current LiabilitesLCE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 20.00% over the past year.
EPS 1Y (TTM)20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, LCE will show a decrease in Earnings Per Share. The EPS will decrease by -9.62% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-3%
EPS Next 2Y-9.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LCE.CA Yearly Revenue VS EstimatesLCE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
LCE.CA Yearly EPS VS EstimatesLCE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.01 -0.02 -0.03

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LCE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LCE.CA Price Earnings VS Forward Price EarningsLCE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LCE.CA Per share dataLCE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

A cheap valuation may be justified as LCE's earnings are expected to decrease with -9.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.62%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LCE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTURY LITHIUM CORP

TSX-V:LCE (3/7/2025, 7:00:00 PM)

0.245

-0.02 (-5.77%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)03-31 2025-03-31/amc
Inst Owners0.01%
Inst Owner ChangeN/A
Ins Owners4.34%
Ins Owner ChangeN/A
Market Cap36.63M
Analysts80
Price Target2.42 (887.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.04%
Min EPS beat(2)2.91%
Max EPS beat(2)61.17%
EPS beat(4)4
Avg EPS beat(4)41.75%
Min EPS beat(4)2.91%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)34.47%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-50%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.36
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.7%
ROE -5.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.6%
ROA(5y)-13.12%
ROE(3y)-7.8%
ROE(5y)-13.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 411539%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.4
Quick Ratio 10.4
Altman-Z 18.23
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-3%
EPS Next 2Y-9.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.13%
OCF growth 3YN/A
OCF growth 5YN/A